Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Juan Carlos Garcia-Zueco"'
Autor:
Mónica Estévez, Jose Francisco Tomas, Pilar Delgado, Juan Carlos Garcia-Zueco, Jose I. Garcia-Cia, Raquel de Oña, Rebeca Iglesias, D. Yague, Antonio Rezusta, Daniel Rubio-Felix
Publikováno v:
Blood. 110:4373-4373
Invasive fungal infections (IFI) remain as an important cause of morbidity and mortality in adult patients with acute leukemia (AL). The incidence of proven or probable mold and yeast infections ranges from 5–24% among this selected high-risk patie
Autor:
Daniel Rubio-Felix, Juan Carlos Garcia-Zueco, Araceli Rubio-Martinez, Valle Recasens, Pilar Giraldo, Pilar Delgado
Publikováno v:
Blood. 108:5094-5094
Background: Bortezomib has been shown to be effective in multiple myeloma (MM), but there is a limited experience in response to re-treatment. Aims: To evaluate the efficacy of Bortezomib in refractory/relapsed MM. Patients and methods: 41 patients t
Autor:
Ignacio de Blas, Araceli Rubio-Martinez, Daniel Rubio-Felix, Pilar Delgado, Pilar Giraldo, Pilar Alfonso, Juan Carlos Garcia-Zueco, Valle Recasens
Publikováno v:
Ignacio de Blas
ResearcherID
ResearcherID
Introduction: AM3(Inmunoferon®), is a glycoconjugate of natural origin with immunomodulatory properties indicated in secondary immnunodeficiencies as well as coadjuvant treatment in neoplastic diseases with cellular immunity deficiency. Aim: To eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b138225effef534f27ce0f1ac4c71464
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000233426102471&KeyUID=WOS:000233426102471
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000233426102471&KeyUID=WOS:000233426102471